BridgeMD
New treatment option for Fracture of Femoral Neck
Official title Clinical Study of a Novel Sliding Compression Locking Plate in the Treatment of Fresh Femoral Neck Fractures
ClinicalTrials.gov ID: NCT06713291
What this study is testing
- What it's testing
- To verify the safety and efficacy of sliding compression locking plates in the treatment of fresh femoral neck fractures
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Age \>=18 years old, gender is not limited;
- Patients diagnosed with femoral neck fracture;
- Patients with indications for internal fixation of femoral neck fracture and able to tolerate surgery;
- The subject or his legal representative is informed of the nature of the study and agrees to participate in the study.
You likely can't join if
- Participants who had participated in clinical studies of other drugs, biologics or medical devices before enrollment and did not reach the primary...
- The patient is known to have a history of allergy to one or more implanted materials;
- Patients determined by researchers to be physically weak or unable to tolerate surgery due to other systemic diseases;
- Active infection of the hip joint or other parts of the body is determined by the investigator;
- Diagnosed as metabolic bone disease, radiation bone disease, etc.;
- Severe hip contracture deformity or severe muscle loss fused to the functional position for a long time without pain;
See the full eligibility criteria
- Age \>=18 years old, gender is not limited;
- Patients diagnosed with femoral neck fracture;
- Patients with indications for internal fixation of femoral neck fracture and able to tolerate surgery;
- The subject or his legal representative is informed of the nature of the study and agrees to participate in the study.
- Participants who had participated in clinical studies of other drugs, biologics or medical devices before enrollment and did not reach the primary study endpoint time limit;
- The patient is known to have a history of allergy to one or more implanted materials;
- Patients determined by researchers to be physically weak or unable to tolerate surgery due to other systemic diseases;
- Active infection of the hip joint or other parts of the body is determined by the investigator;
- Diagnosed as metabolic bone disease, radiation bone disease, etc.;
- Severe hip contracture deformity or severe muscle loss fused to the functional position for a long time without pain;
- have inflammatory arthritis, such as rheumatoid arthritis, systemic lupus erythematosus arthritis, ankylosing spondylitis, etc.;
- The patient is mentally incapable or unable to understand the requirements of participating in the study, and it is difficult to cooperate;
- Other conditions deemed unsuitable for inclusion by the investigator.
The study team makes the final eligibility decision.
Where it's taking place
- Beijing, Beijing Municipality, China
- Beijing, China
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Beijing, Beijing Municipality, China; Beijing, China. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.